KDM6B and breast carcinoma: Programmed death ligand (PD-L1) maintains CSC stemness by promoting OCT4 phosphorylation, but the histone demethylase jumonji domain-containing protein-3 (JMJD3) decreases breast cancer stem cell-like properties by downregulating OCT4 [80,81].